CDMO Avid Bioservices Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDMO

Price (delayed)

$7.35

Market cap

$466.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.28

Enterprise value

$630.77M

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a ...

Highlights
Avid Bioservices's quick ratio has plunged by 74% YoY but it has increased by 10% from the previous quarter
The company's EPS has shrunk by 115% YoY and by 47% QoQ
CDMO's net income has dropped by 115% year-on-year and by 47% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://avidbio.com
Peers: NEOG NTRA MYGN

Key stats

What are the main financial stats of CDMO
Market
Shares outstanding
63.48M
Market cap
$466.58M
Enterprise value
$630.77M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.58
Price to sales (P/S)
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.61
Earnings
Revenue
$136.74M
EBIT
-$17.96M
EBITDA
-$7.83M
Free cash flow
-$38.5M
Per share
EPS
-$0.28
Free cash flow per share
-$0.61
Book value per share
$2.85
Revenue per share
$2.16
TBVPS
$7.19
Balance sheet
Total assets
$455.23M
Total liabilities
$275.06M
Debt
$194.9M
Equity
$180.17M
Working capital
-$119.3M
Liquidity
Debt to equity
1.08
Current ratio
0.46
Quick ratio
0.22
Net debt/EBITDA
-20.97
Margins
EBITDA margin
-5.7%
Gross margin
7.5%
Net margin
-13.2%
Operating margin
-12.1%
Efficiency
Return on assets
-4%
Return on equity
-9.7%
Return on invested capital
-4.5%
Return on capital employed
-7.7%
Return on sales
-13.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDMO stock price

How has the Avid Bioservices stock price performed over time
Intraday
0.41%
1 week
15.02%
1 month
8.25%
1 year
-59.17%
YTD
13.08%
QTD
9.7%

Financial performance

How have Avid Bioservices's revenue and profit performed over time
Revenue
$136.74M
Gross profit
$10.21M
Operating income
-$16.55M
Net income
-$17.98M
Gross margin
7.5%
Net margin
-13.2%
The company's net margin has shrunk by 116% YoY and by 52% QoQ
CDMO's net income has dropped by 115% year-on-year and by 47% since the previous quarter
The operating margin has dropped by 73% since the previous quarter
The operating income has plunged by 68% from the previous quarter

Growth

What is Avid Bioservices's growth rate over time

Valuation

What is Avid Bioservices stock price valuation
P/E
N/A
P/B
2.58
P/S
3.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.61
The company's EPS has shrunk by 115% YoY and by 47% QoQ
CDMO's price to book (P/B) is 75% less than its 5-year quarterly average of 10.4 and 30% less than its last 4 quarters average of 3.7
Avid Bioservices's equity has decreased by 2.8% YoY
CDMO's P/S is 56% below its 5-year quarterly average of 7.8 and 28% below its last 4 quarters average of 4.7
CDMO's revenue is down by 3% since the previous quarter and by 2.8% year-on-year

Efficiency

How efficient is Avid Bioservices business performance
CDMO's return on equity has dropped by 115% year-on-year and by 49% since the previous quarter
The return on assets has dropped by 115% year-on-year and by 48% since the previous quarter
The company's return on sales has shrunk by 115% QoQ
Avid Bioservices's return on invested capital has shrunk by 114% QoQ

Dividends

What is CDMO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDMO.

Financial health

How did Avid Bioservices financials performed over time
The total assets is 66% greater than the total liabilities
Avid Bioservices's quick ratio has plunged by 74% YoY but it has increased by 10% from the previous quarter
CDMO's current ratio has dropped by 70% year-on-year and by 4.2% since the previous quarter
The company's debt is 8% higher than its equity
The debt to equity is up by 11% YoY
The company's debt rose by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.